Search

US12605402B2 Oxidizing Acid Solution Patent Grant

The USPTO granted patent US12605402B2 to APR Applied Pharma Research SA covering methods for treating Epidermolysis Bullosa (EB), EGFR inhibitor-induced skin toxicities, Hailey-Hailey Disease (HHD), Buruli Ulcers, and SARS-CoV-2 infections using topical hypotonic acid oxidizing solutions containing hypochlorous acid (HClO). The patent contains 22 claims and was filed on July 2, 2020 under application number 17597220. This grant confers enforceable intellectual property rights to the assignee but does not itself impose compliance obligations on other market participants.

VA Cooperative Studies Program Importer Controlled Substances

The DEA published notice that VA Cooperative Studies Program applied on April 9, 2026, to be registered as an importer of controlled substances for research purposes. The application covers Marihuana Extract (Drug Code 7350) and Tetrahydrocannabinols (Drug Code 7370), Schedule I controlled substances, which the company plans to import as finished dosage unit products for clinical trial studies only. The DEA is accepting electronic comments and written hearing requests on the application through May 21, 2026.